【出版时间及名称】：2009年11月印度制药行业研究报告
        【作者】：野村证券
        【文件格式】：PDF
        【页数】：35
        【目录或简介】：

Table of Contents
Snapshot of the Indian pharmaceutical market (IPM) ................................................. 3
Domestic formulation sales — by company ............................................................. 4
Cipla Ltd (CIPLA IN, REDUCE) ........................................................................... 4
Ranbaxy Laboratories Ltd (RBXY IN, REDUCE) ....................................................... 6
GlaxoSmithKline Pharmaceuticals Ltd (GLXO IN, NEUTRAL) ..................................... 8
Piramal Healthcare Ltd (PIHC IN, BUY) .............................................................. 10
Cadila Healthcare Ltd (CDH IN, not rated)......................................................... 12
Sun Pharma (SUNP IN, REDUCE) ..................................................................... 14
Alkem (not listed) ........................................................................................... 16
Lupin Ltd (LPC IN, BUY)................................................................................... 18
Mankind (not listed) ....................................................................................... 20
Aristo Pharma (not listed) ................................................................................. 22
Dr Reddy’s Laboratories Ltd (DRRD IN, BUY) ....................................................... 24
Glenmark Pharmaceuticals Ltd (GNP IN, BUY) .................................................... 26
Domestic formulations — breakdown by therapy.................................................... 28
Anti-infectives ................................................................................................ 28
Cardiovascular (CVS)..................................................................................... 28
Gastrointestinal ............................................................................................. 29
Respiratory ................................................................................................... 29
Pain/analgesics............................................................................................ 30
Vitamins/minerals/nutrients ............................................................................. 30
Gynaecology ............................................................................................... 31
Dermatology................................................................................................. 31
Neurology (CNS).......................................................................................... 32
Anti-diabetic ................................................................................................. 32